                         SEQUENCE LISTING

<110>  Immune System Key Ltd.
 
<120>  POLYPEPTIDES FOR USE IN THE TREATMENT AND PREVENTION OF 
       NEURODEGENERATIVE DISEASES

<130>  2830420

<150>  US 63/109,484
<151>  2020-11-04

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide termed "dTCApFs"


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is equal to D-Thr

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is equal to D-Phe

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is equal to D-Phe

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is equal to D-Leu

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is equal to D-Pro

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is equal to D-Ser

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is equal to D-Thr

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is equal to D-Leu

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is equal to D-Trp

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is equal to D-Glu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is equal to D-Arg

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is equal to D-Lys

<400>  1

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  L-amino acid peptide of "dTCApFs"

<400>  2

Trp Trp Thr Phe Phe Leu Pro Ser Thr Leu Trp Glu Arg Lys 
1               5                   10                  


